Preston Robert Tisch Brain Tumor Center at Duke

Meet Peter E. Fecci, MD, PhD, the Director of the Brain Tumor Immunotherapy Program and the Center for Brain and Spine Metastasis at the Preston Robert Tisch Brain Tumor Center at Duke. Dr. Fecci and his team are pioneering immune-based treatment platforms for patients with brain tumors, focusing on reversing T cell dysfunction in conditions like glioblastoma and brain metastases. Dr. Fecci’s groundbreaking research on T cell exhaustion and sequestration is driving new strategies to enhance immunotherapy, aiming to transform the way we treat brain tumors. His work is at the intersection of research, neurosurgery, and patient care, striving to make cutting-edge immunotherapy a reality for brain tumor patients. Learn more about Dr. Fecci and his innovative work by visiting the lab page at https://lnkd.in/eBcZBfRx. 🧠🔬 #CancerResearch #Immunotherapy #LabSpotlight #DukeBrainTumorCenter

At the Preston Robert Tisch Brain Tumor Center at Duke, our clinical social workers are the heart of patient support 💙. They provide more than just emotional guidance—they help patients and families navigate the complex challenges of brain tumor care. From diagnosis through recovery, they offer practical resources, compassionate counseling, and a listening ear. Their role ensures that patients receive the comprehensive, whole-person care they need to face each step of their journey with confidence and support. Learn more about the incredible work they do by visiting our website at https://lnkd.in/eN6uruMX #MeetTheTeam #BrainTumorCare #DukeBrainTumorCenter

Approximately 10-30% of patients with metastatic breast cancer will develop brain metastases. At the Preston Robert Tisch Brain Tumor Center at Duke, we stand with those battling breast cancer and provide care for patients facing metastatic brain cancer. In collaboration with #DukeMets, we’re committed to raising awareness and supporting advanced care for brain metastases. To learn more about their streamlined care for metastatic brain and spine lesions, visit: https://lnkd.in/eASGFiWJ. Source: Sammon SL, Leone JP, Sanglier T, et al. Brain metastases in metastatic breast cancer: prevalence per line of treatment and cumulative incidence in a cohort of 18,075 real-world patients. Presented at: San Antonio Breast Cancer Conference; December 5-9, 2023; San Antonio, TX. Abstract PS11-01. #MetastaticBreastCancerAwareness #BrainCancerAwareness #DukeBrainTumorCenter #DukeMets #BreastCancerAwarenessMonth #MetsGetsAwareness

At the Preston Robert Tisch Brain Tumor Center at Duke, we recognize the profound impact mental health has on overall well-being, especially for brain tumor patients and caregivers. On World Mental Health Day, we’re reminded that prioritizing mental health is essential for healing, strength, and resilience. Facing a brain tumor diagnosis can be overwhelming, and it’s important to remember that mental health care is a vital part of the treatment process. Today, we encourage you to take time for self-care, connect with loved ones, and seek support when needed. Remember, we are here for you, and your mental health matters just as much as your physical health. 💙 #MentalHealthMatters #WorldMentalHealthDay

Meet Karen J. Dean, MSN, APRN, AGACNP-BC, a dedicated nurse practitioner specializing in neurology and neurosurgery at the Preston Robert Tisch Brain Tumor Center at Duke. Karen works closely with primary brain tumor patients, providing compassionate, open communication with both patients and their families. She is committed to ensuring the highest quality of life for those facing difficult diagnoses, fostering hope and resilience in the face of challenges. Karen deeply values the personal connections made with her patients, admiring their determination and strength throughout their journey. Outside of work, Karen enjoys spending time with family, staying active through exercise, and discovering new foods and travel destinations. Learn more about the exceptional professionals at the PRTBTC who make a difference every day! #MeetTheTeam #DukeBrainTumorCenter #HealthcareHeroes

In today's Friday Message, Dr. Mary E. Klotman talks with David M. Ashley, MBBS (Hon), FRACP, PhD, director of the Preston Robert Tisch Brain Tumor Center at Duke, about the challenges of treating brain tumors and recent advancements, including an FDA-approved drug for low-grade gliomas. Dr. Ashley also shares his vision for the future of brain cancer treatment and Duke’s role in these developments.

Amanda’s story is one of resilience, and at Duke, we’re honored to walk alongside her in her journey as a survivor. 💙 At the Preston Robert Tisch Brain Tumor Center at Duke, we believe in the power of compassionate care and community, where every patient feels valued and supported. At Duke, there is HOPE—this isn’t just a word for us, it’s our guiding belief and a promise to every patient we serve. To learn more about our center or get in touch with our team, give us a call at 919.684.5301. #HopeAtDuke #DukeBrainTumorCenter

Happy National Physician Assistant Day! 🌟 Today, we celebrate the incredible contributions of our dedicated Physician Assistants at the Preston Robert Tisch Brain Tumor Center at Duke. From providing compassionate patient care to assisting in complex treatments, our PAs are essential members of the team. Their expertise, empathy, and commitment to improving the lives of brain tumor patients make a lasting impact every day. Thank you for all you do! 🙏💙 #NationalPhysicianAssistantDay #DukeBrainTumorCenter #HealthcareHeroes

🎙️ In this special Friday Message, Mary E. Klotman M.D., Dean of the Duke University School of Medicine, speaks with David M. Ashley, MBBS, FRACP, PhD, MBBS (Hons), director of the Preston Robert Tisch Brain Tumor Center at Duke, to discuss the latest breakthroughs in brain tumor treatment. 💡 From the challenges of treating these complex diseases to exciting advancements—like the newly FDA-approved drug for low-grade gliomas — Dr. Ashley shares his expert insights and Duke's role in shaping the future of brain cancer care. 🧠✨ Tune in for an inspiring conversation on what’s ahead in the fight against brain tumors! #BrainTumorResearch #Glioma #DukeBrainTumorCenter

Yesterday at the annual Preston Robert Tisch Brain Tumor Center at Duke motivational luncheon, Coach K delivered an unforgettable speech to the entire BTC staff. He touched on the importance of resilience, teamwork, and staying focused on our mission. His message was powerful and left a lasting impression on everyone in the room. It was a reminder of why the work we’re doing is so impactful and how much of a difference we’re making in the lives of others. Truly an inspiring day for all of us! 💙 #CoachK #DukeBrainTumorCenter